144 related articles for article (PubMed ID: 1498315)
21. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA
Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
[TBL] [Abstract][Full Text] [Related]
22. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético.
Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A
Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172
[TBL] [Abstract][Full Text] [Related]
23. [Bone marrow transplantation from an unrelated donor in patient with congenital heart diseases].
Kumazaki H; Hanada R; Kikuchi A; Ichikawa M; Yamamoto K; Aoyagi H
Rinsho Ketsueki; 1996 Aug; 37(8):731-3. PubMed ID: 8827886
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
Gratwohl A; Hermans J; Niederwieser D; Frassoni F; Arcese W; Gahrton G; Bandini G; Carreras E; Vernant JP; Bosi A
Bone Marrow Transplant; 1993 Nov; 12(5):509-16. PubMed ID: 8298562
[TBL] [Abstract][Full Text] [Related]
25. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors. Value in donor selection.
Spencer A; Brookes PA; Kaminski E; Hows JM; Szydlo RM; van Rhee F; Goldman JM; Batchelor JR
Transplantation; 1995 May; 59(9):1302-8. PubMed ID: 7762066
[TBL] [Abstract][Full Text] [Related]
27. [Allogeneic cryopreserved marrow transplantation in a patient with chronic myelogenous leukemia].
Akatsuka Y; Takeshita T; Tsuzuki S; Suzuki R; Sugihara T; Minami S; Kodera Y
Rinsho Ketsueki; 1994 Mar; 35(3):304-8. PubMed ID: 8158854
[TBL] [Abstract][Full Text] [Related]
28. Long-term follow-up after bone marrow transplantation for chronic myelogenous leukemia: factors associated with relapse.
Devergie A; Reiffers J; Vernant JP; Herve P; Guyotat D; Maraninchi D; Rio B; Michallet M; Jouet JP; Milpied N
Bone Marrow Transplant; 1990 Jun; 5(6):379-86. PubMed ID: 2088319
[TBL] [Abstract][Full Text] [Related]
29. Sustained molecular remission in a patient with CML in blastic crisis receiving dose-reduced hematopoietic stem-cell transplantation followed by early withdrawal of cyclosporine and prophylactic use of interferon-alpha.
Hamaki T; Kami M; Momomura S; Mineishi S; Kusumi E; Kanda Y; Ueyama J; Miyakoshi S; Morinaga S; Takaue Y; Mutou Y
Am J Hematol; 2002 Nov; 71(3):196-9. PubMed ID: 12410575
[TBL] [Abstract][Full Text] [Related]
30. [Rapid onset of hemolytic anemia after allogeneic bone marrow transplantation from an unrelated ABO major mismatched donor].
Watanabe H; Asai O; Tada N; Yano S; Katoh A; Katori M; Kobayashi T; Kuraishi Y; Hoshi Y; Itoh K; Aizawa S
Rinsho Ketsueki; 1997 Jan; 38(1):14-20. PubMed ID: 9028156
[TBL] [Abstract][Full Text] [Related]
31. [Successful engraftment of HLA-identical sibling cord blood transplantation in an adult with chronic myelogenous leukemia].
Ren H; Guo N; Lu D
Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):621-4. PubMed ID: 16200707
[TBL] [Abstract][Full Text] [Related]
32. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
33. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
[TBL] [Abstract][Full Text] [Related]
34. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
Topolsky D; Crilley P; Styler MJ; Bulova S; Brodsky I; Marks DI
Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353
[TBL] [Abstract][Full Text] [Related]
35. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings.
Bunin NJ; Casper JT; Lawton C; Murray K; Camitta BM; Greenwood M; Geil J; Ash RC
Bone Marrow Transplant; 1992 Feb; 9(2):119-22. PubMed ID: 1571710
[TBL] [Abstract][Full Text] [Related]
37. Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution.
Sanz GF; Saavedra S; Jiménez C; Senent L; Cervera J; Planelles D; Bolufer P; Larrea L; Martín G; Martínez J; Jarque I; Moscardó F; Plumé G; Andreu R; de la Rubia J; Barragán E; Solves P; Soler MA; Sanz MA
Bone Marrow Transplant; 2001 Apr; 27(7):693-701. PubMed ID: 11360108
[TBL] [Abstract][Full Text] [Related]
38. Low incidence of acute GVHD in patients transplanted with marrow from HLA-A,B,DR-compatible unrelated donors among Japanese.
Morishima Y; Kodera Y; Hirabayashi N; Tanimoto M; Matsuyama T; Horibe K; Ohta H; Mizuno S; Morishita Y; Yamauchi T
Bone Marrow Transplant; 1995 Feb; 15(2):235-9. PubMed ID: 7773212
[TBL] [Abstract][Full Text] [Related]
39. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
40. [Successful treatment of recurrent chronic myelogenous leukemia in allogeneic marrow transplant recipient with the donor leukocyte transfusion, without induction of acute graft-versus-host disease].
Yamazaki H; Nakao S; Takamatsu H; Ito T; Ueda M; Shiobara S; Matsuda T
Rinsho Ketsueki; 1995 Jul; 36(7):677-81. PubMed ID: 7563596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]